Pre-emptive Prevention for Patients at High Risk for Hospital-onset Clostridioides Difficile
A Pre-emptive Prevention Bundle for Patients at High Risk for Hospital-onset Clostridioides Difficile
Sponsor: Brigham and Women's Hospital
Listed as NCT05389904, this NA trial focuses on C. Difficile and remains actively recruiting participants. Sponsored by Brigham and Women's Hospital, it has been updated 8 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Mar 2026 — Present [monthly]
Recruiting NA
-
Sep 2025 — Mar 2026 [monthly]
Recruiting NA
-
Sep 2024 — Sep 2025 [monthly]
Recruiting NA
-
Aug 2024 — Sep 2024 [monthly]
Recruiting NA
-
Jul 2024 — Aug 2024 [monthly]
Recruiting NA
▶ Show 3 earlier versions
-
Sep 2022 — Jul 2024 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jul 2022 — Sep 2022 [monthly]
Not Yet Recruiting NA
-
Jun 2022 — Jul 2022 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Brigham and Women's Hospital
- Centers for Disease Control and Prevention
- Harvard Pilgrim Health Care Institute
- Hatch Family Foundation
- Massachusetts Host-Microbiome Center
For direct contact, visit the study record on ClinicalTrials.gov .